Upload
charissa-santana
View
48
Download
0
Tags:
Embed Size (px)
DESCRIPTION
Expanding Regulated Private Sector Medicines Access - Experiences with Accredited Drug Dispensing Outlets. Romuald Mbwasi, PhD. What is Wrong with Drug Sellers?. ADDO program takes a holistic approach to address drug seller problem through a “package of interventions”. - PowerPoint PPT Presentation
Citation preview
Expanding Regulated Private Sector Medicines Access - Experiences with Accredited Drug Dispensing Outlets
Romuald Mbwasi, PhD
What is Wrong with Drug Sellers?
Build private sector capacity Business skills of owners Dispensing and communication skills
Provide incentives Ability to sell expanded range of legally sold medicines Loans
Enhance availability and quality of products Products in stock approved by national drug authorities Local suppliers
Ensure quality of pharmaceutical services Record keeping Mentoring and supervision
Increase patient and consumer awareness Marketing Information and education
ADDO program takes a holistic approach to address drug seller problem through a “package of interventions”
Decrease in Inappropriate Recommendation of Antibiotics for Upper Respiratory Tract Infection (URTI)
39%
14%
25%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
SEAM 2001Assessment (DLDB
Countrywide)
Ruvuma ADDOsEndline
Singida DLDBEndline
Source: Management Sciences for Health. 2005. SEAM Tanzania Final ADDO Report.
Endline data of inappropriate antibiotic dispensing for URTI by
ADDOs in the pilot region was 14% compared with 39% at baseline. At endline in the control region, 25 percent
inappropriate dispensing was found.
Quality of Service (1)Percent of Drug Outlets Dispensing Malaria Treatment
According to STG-Ruvuma
2002 2004 2010
6%
24%
63%Chart Title
Outcome measure: sustainability of quality of services
Quality of Pharmaceutical Products: Percent of products available in ADDOs that were Not Registered with TFDA
Baseline 2001 Endline 2004 ADDOs 2010
26%
2%0%
Availability of Antimalarial Products in ADS Uganda
Kibaale Mpigi Kibaale Mpigi Kibaale MpigiALU Chloroquine SP
5% 6%
80%73%
100% 100%
87% 90%
2%
32%
7%
85%
BaselineEndline
Outcome measure: dramatic decline of SP and CQ which are not recommended
in the STG for uncomplicated malaria following accreditation in Kibaale
Challenges and Opportunities• Although overall dramatic improvement in rational use is observed,
gaps exists in management of certain conditions, like diarrhea• Lack or minimal consumer education and advocacy is a challenge• Collaboration with different health programs offers opportunities for
improving rational medicines use • The insurance schemes such as NHIF which has accredited ADDO is
another opportunity for quality of services monitoring including rational medicines use
• While market can help in reducing price and improving availability, this should not be done at the expense of rational use of medicines and quality of services